type 2 diabetes
Conditions
Interventions
Insulin glulisine was Administered before every meals. Insulin dose is adjusted every day based on the results of blood glucose self-measurement.
insulin glargine was Administered before every sleep
Sponsors
Department of Disease Control and Homeostasis,kanazawa University Graduate School of Medical Science.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The subjects must satisfy the following conditions: 1) An age at the time of obtaining informed consentis more than 20 years old 2) Patients with type 2 diabetes, whose HbA1c is more than 7.4%. 3) Gender is unquestioned: 4) Patients who are admitted to the purpose of glycemic control more than two weeks
Exclusion criteria
Exclusion criteria: 1.Hypersensitivity to components of the insulin glargine and insulin glulisine. 2.None Type 2 diabetes 3.Medical history and/or complication of diabetic ketoacidosis. 4.Medical history and/or complication of severe hypoglycemia. 5.severe infection, around surgery or severe trauma. 6.Patients who received the administration of insulin, DPP-4 inhibitors or GLP-1 analog formulation within 4 weeks. 7.Treatment with glucocorticoid. 8.Uncontrolled Hypertension(systolic blood pressure >160 mmHg or diastolic blood pressure >100 mmHg) 9.Proliferative retinopathy or maculopathy. 10.History of malignancy. 11.Severe health problems not suitable for the study. 12.Patients participated in other clinical trials within one month before the study. 13.Cases that Physicians deem inappropriate as the target of the test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| M values | — |
Countries
Japan
Contacts
Public ContactTAKAMURA Toshinari
kanazawa University Graduate School of Medical Science. kanazawa University Graduate School of Medical Science.
Outcome results
None listed